chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ABOUT TWO WEEKS AFTER THE 2ND PFIZER COVID VACCINE I DEVELOPED DYSPNEA ON EXERTION AFTER WALKING FOR N + MILE (I WALK DAILY APPROX 3 MILES.. NEVER HAD ANY PROBLEMS). IT WAS STRANGE -TAKING DEEP BREATHS DID NOT HELP. INITIALLY I THOUGHT I MAY HAVE THROMBOTIC COMPLICATION, OR A CARDIOMYOPATHY RELATED TO SOME VIRUS. SINCE I WAS ABLE TO WALK DAILY 1-3 MILES I DID NOT SEEK MEDICAL HELP, ALSO, THESE SYMPTOMS OF DAILY DYSPNEA ON EXERTION (N + MILE) LASTED N 2 WKS - AND COMPLETELY RESOLVED IN ADDITIONAL 2 WKS. NOW I THINK THAT THESE SYMPTOMS MIGHT HAVE BEEN RELATED TO THE COVID VACCINE (AND WANT TO INFORM POTENTIAL GUIDANCE FOR THE USE OF MRNA FOR REVACCI- NATIONS FOR INDIVIDUALS WITH SIMILAR COMPLICATIONS.  ALSO, I FILED A PREVIOUS REPORT - I DEVELPOED MULTIPLE JOINT EFFUSIONS AFTER THE 1ST AND 2ND  DOSE COVID VACCINE - IT TOOK A COUPLE OF MONTHS BUT BY NOW THESE SYMPTOMS ARE RESOLVED.
This is a spontaneous report from a contactable physician who reported for herself. This 65-year-old female patient received the first single dose of PREVNAR 13 via an unspecified route of administration on 15Jan2015. The physician mentioned that she got the first PREVNAR 13 and a month later on 15Feb2015 she was scheduled to receive PNEUMOVAX 23. Medical history included high blood pressure from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. On 15Jan2015, the patient experienced some arrhythmia and sliding duration, no pain. The physician mentioned that she did undergo an unspecified blood test on an unspecified date in Jan2015 for which the results were normal. She suspected that the vaccine had caused the local reaction which she noticed in the night of 22Jan2015. Since the patient was not recovered from the reported events, she wanted to know whether it was safe for her to get the other scheduled PNEUMOVAX 23. The physician mentioned that she believed that PREVNAR 13 would have been shaken surely by her medical assistant who gave her the vaccine and further mentioned that she did not know whether she shook it. The physician just told her to prepare and give her the shot and the storage conditions were excellent at her facility. The vaccine was whitish in color. It was not frozen and she mentioned that if it was frozen she would have thrown it away. She also mentioned that she took no treatment for that local reaction and any other thing. She assessed some arrhythmia and local reaction as related to PREVNAR 13. Follow-up (19Feb2015): Follow-up attempts not possible. No follow-up information expected.
Patient given 0.25mL dose of Moderna in her right arm instead of 0.5mL. Discovered the error. The patient returned to the clinic. An additional 0.25mL dose of Moderna  administered approximately 2 hours later in her left arm.
Malaise; Headache; Nausea; reactions to the vaccine; Vertigo; Balance issue; dizzy sensation; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (reactions to the vaccine), MALAISE (Malaise), VERTIGO (Vertigo), BALANCE DISORDER (Balance issue) and DIZZINESS (dizzy sensation) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Dec-2020, the patient experienced ADVERSE EVENT (reactions to the vaccine), VERTIGO (Vertigo), BALANCE DISORDER (Balance issue) and DIZZINESS (dizzy sensation). On 28-Jan-2021, the patient experienced MALAISE (Malaise), HEADACHE (Headache) and NAUSEA (Nausea). At the time of the report, ADVERSE EVENT (reactions to the vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 27-Jan-2021: No specific follow-up information recorded.
Reported having itchy hives (rash) all over his body from 4/15/12 through 4/19/12. Pt took high doses of Benadryl & loratadine x 3 1/2 days.
Moderna dose was drawn up and administered after recommended 12-hour punctured Beyond Use Date (BUD) but before recommended 24-hour room temperature unpunctured BUD
21 yo Mwith no PMHX  accompanied by mother for single dose J&J vaccine at approximately 11:50am. Approximately 30 seconds after vaccine administration, patient experienced syncopal episode with persistent orthostatic vital sign changes. Brief LOC witnessed, patient did not fall over. When patient moved from sitting to laying position, BP dropped and HR elevated slightly. Patient denies n/v, HA, dizziness, visual changes, tinnitus. Patient denies allergies or previous episode of syncope. Condition improved with time. Vitals laying BP 100/61, Pulse 53, O2 91%, RR 12, sitting up BP 100/50, Pulse 70, O2 98%, RR12. EMS called and pt transferred to ER for medical eval.
9/2/14 Pt's mother reported she heard screaming in her head. Pt seen by PCP and psych.
Fully vaccinated, no booster.   COVID breakthrough infection with inpatient hospital stay.   Patient baseline is vent dependent.
I woke up with extreme sore throat and post nasal drip. I had an extreme cough. I wen to the urgent care and got a PCR covid test which was negative/.
Systemic: Tachycardia-Medium, Additional Details: Difficulty swallowing
Vaccination Status - moderna x4 + Pfizer BIVALENT   BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider at Discharge: NP   Admission Date: 12/28/2022 Discharge Date: 01/01/2023     HOSPITAL COURSE: Per HPI or hospital summary: " Patient is a 72 y.o. female  Past medical history as noted below   History of non-small cell done carcinoma status post left lower lobectomy Diagnosed initially via biopsy April of 2022 0 Lobectomy done May of 2022.   Brain MRI and PET CT negative for metastatic disease Patient had underwent cisplatin treatment which caused some renal insufficiency. Cisplatin held due to this.  Plans for repeat CT in January   Comes in primarily due to shortness of breath over the past several days Has also had worsening cough, congestion, myalgia, general malaise Recent travel during the holiday but with no known sick contacts   The emergency department,  CT angiogram thorax showed multiple new small patchy areas of airspace disease in the right upper lobe and left lower lobe Concern for multifocal pneumonia or pneumonitis Stable small bilateral pulmonary nodules   "   Interim hospital course:  Patient hospitalized for viral pneumonia with etiology identified as rhinovirus as well as coronavirus.  In addition patient was treated for superimposed community-acquired pneumonia, received 4 days of IV antibiotics discharge within 1 additional day of oral antibiotic Augmentin to complete a course of therapy.  Patient improved with supportive management in addition antitussive medications which will be continued on discharge.  In addition patient had acute kidney injury on chronic kidney disease on admission likely secondary to the above mentioned problems and dehydration.  Following initial fluid resuscitation and supportive management her renal function improved with the assistance of Nephrology.  Patient will remain on her home medications at time of discharge.  Recommend follow-up with primary care team in 1 week to ensure resolution of symptoms and for repeat labs.  Recommend follow-up with Dr. does her oncology physician in the next 1 month.  Nursing reporting the patient is ambulatory independently in the room, no need for additional therapy evaluation at this time.  Discussed care with patient and her family member prior to discharge.  Medically stable for discharge on 01/01/2023.  Patient reports she was not taking Norvasc at home and blood pressures were borderline during her admissions of this was discontinued on discharge.
My daughter received her vaccines on 5/12/20 at 12 months old. She had a virus on  5/2-5/4-20 with a 104-105 degree fever with no other symptoms. She was cleared for her vaccines on 5/12/20 since no fever was present. On 5/28/20 she started getting a rash then got petechiae and had a nose bleed the morning of 5/29/20. I took her to the pediatrician who immediately sent us to have a platelet count at the hospital. The Platelet count came back at 2,000 and we immediately went to the ER.  After more testing and a few questions on other counts they ruled out Leukemia. The Doctors told me it was ITP most likely caused by the MMR vaccine in addition the active virus from 5/2/20. After a platelet transfusion her platelet levels increase and a month later they were back to normal.  They did warn me that she could possibly have reactions to other vaccines and their was  a small chance she could develop an autoimmune disorder from the ITP.
feel bad for just two days; This case was reported by a consumer via interactive digital media and described the occurrence of feeling bad in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced feeling bad. On an unknown date, the outcome of the feeling bad was recovered/resolved.   It was unknown if the reporter considered the feeling bad to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 14-OCT-2022 Reporter's Comment: The pharmacist reported this case via interactive digital media. The pharmacist told him/her that the people typically felt bad for just two days. Additional supportive information: The follow-up would not possible, as no contact, details were available. This case had been linked with case US2022AMR148244, reported by the same reporter.; Sender's Comments:  US-GSK-US2022AMR148244:Same reporter
Temp 100.4F, headache, muscle aches, bony aching, nausea, reduced appetite, fatigue. All resolved after 1 day except fatigue resolved after 2 days
Red, bumpy rash started Feb.20, 2021 on upper right arm.  At first, area was  somewhat itchy and occasionally sensitive to touch.  Bumps are disappearing and area became less red as time goes on but is still visible.
Subsequent to receiving one dose of varicella virus vaccine live the pts varicella zoster virus IgG antibody was less than 10 ETA units which is indicative of a low titer. Consequently the pt received a second dose of varicella virus vaccine live.
I had a lot of sinus drainage and was trying to clear it, but it wouldn't clear. After about a year, I had enough and contacted my NP in Jan. I was referred to an ENT doctor. It was offered to do a nasal cam, but I refused. Was advised to use a saline neti pot to clear sinus. As of now I still have sinus issues and have not recovered. Will be setting an appt. with a Gastroenterologist.
FELT FLUSH, DEVELOPES RASH ON CHEST. GIVEN IV DIPHENHYDRAMINE AND NORMAL SALINE BOLUS. DECLINED EMS AFTER RECEIVING ADVICE FROM ER DR, NP AND EMS
not hungry; a little achy; fever of 100; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (not hungry), PAIN (a little achy) and PYREXIA (fever of 100) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 030O20A) for COVID-19 vaccination.     Concomitant products included LOSARTAN, FLUOXETINE, OMEPRAZOLE, SPIRONOLACTONE and LEVOTHYROXINE for an unknown indication.   On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced DECREASED APPETITE (not hungry), PAIN (a little achy) and PYREXIA (fever of 100). The patient was treated with PARACETAMOL (TYLENOL) on 02-Feb-2021 at a dose of 2 in the evening. At the time of the report, DECREASED APPETITE (not hungry), PAIN (a little achy) and PYREXIA (fever of 100) outcome was unknown.            Treatment medication included Tylenol.
Pt recv vax on 10/27/98; on same day pt exp fever; 10/28/98 pt exp vomiting & diarrhea; pt imp 11/4/98
Fever, chills, body aches, migraine, fatigue, dizziness, nausea, vomiting, for the entire day after receiving the vaccine.
Patient first noticed his arm was itching where he received the shot on 12/12/2019 and the morning of 12/13/2019 the patient noticed a blister like red circular rash around the injection site.
Swelling and redness on injection site. Welt of about 1 inch in diameter. Itchiness and mild irritation  was noticed.
"passed  out" approx 1 min after receiving covid  vaccine. -epi pen administed in thigh by pharmacist no s2 activity no Resp distress total LDC=1 min
I have had headaches; fever - as high as 103.9; I have had a cough and congestion and wheezing in the chest; difficulty in breathing and extreme fatigue. I am still having the symptoms though not as severe. I am waiting for CT scan of my chest. The first x-ray, 4-28, I was on amoxicillin.  I went on on SAME DAY CENTER (Urgent care of my family doctor) for that. My family put me on another week of amoxicillin. I went to doctor was put on Prednisone and Albuterol sulfate - and then I went on Breo -Inhaler and another type of antibiotic (twice a day for three days when my symptoms got worse) and so I went to the SAME DAY CTR and they put me on Levaquin - took me off the other antibiotic. Doctor also had me taking Mucinex twice a day. As of Friday, I haven't taken anything besides Alka-Seltzer Plus.
12/20/21 presents to ED for "weakness and body aches". PMHx of "DM-II, HTN, ESRD on HD MWF, HLD, GERD"
This case was reported by a consumer via call center representative and described the occurrence of shivering in a 68-year-old female patient who received SHINGRIX for prophylaxis. On 22nd February 2019, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, less than a month after receiving SHINGRIX, the patient experienced shivering, injection site pain, fatigue and injection site erythema. On an unknown date, the outcome of the shivering, injection site pain, fatigue and injection site erythema were recovered/resolved. It was unknown if the reporter considered the shivering, injection site pain, fatigue and injection site erythema to be related to SHINGRIX. Additional details were provided as follows: The age at the vaccination was not reported. The patient received a dose of SHINGRIX on left arm. The patient experienced fatigue and shivering after receiving the vaccine. Patient also developed pain and redness at the injection site. The patient stated that the red spot was approximately the same size as match book (box). The injection site redness disappeared within 1 week. Consent to follow up was requested.
I was actually out of town and the symptoms where very sudden extreme exhaustion and stuffy nose, and this lasted for 36 hours. I started to feel a little better and then proceed to drive home which was a 4-hour drive. I then tested myself 48 hours later it was immediately positive for COVID-19. I called my doctor, and it was a Sunday, so I had to wait for them to call me back which they did. Once I spoke to the doctor, they said I would be a perfect candidate for PAXLOVID. They called in the prescription, and I started the medication 48-hours later. I was already starting to feel better. After the 5 days of medication, I tested again, and I was negative. Then a few days later I tested again just to be sure, and it was positive for COVID-19, so it was a rebound case. I didn't really feel bad I just had a runny nose. Then I waited a few more days and tested again and this time I was negative.
Shingles; This spontaneous case was reported by a nurse and describes the occurrence of HERPES ZOSTER (Shingles) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Shingles). At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.  Patient was scheduled for the second dose of the Moderna vaccine in Feb 2021, next week since the reported date, but was diagnosed with shingles after having those symptoms. Patient stated that she was informed by her HCP to wait to get the Moderna vaccine because of the shingles diagnosis.
Sore arm. Can't lift arm above head. Described as a nagging toothache.
Monday evening 11:20 pm nausea and stomach pain which dissipated 2 hours later:  dark brown urine continues into day 2
2/24/09REPORTED TO PEDIATRICIAN ABOUT HIGH FEVER. TYLENOL NOT WORKING. BY 2/28/09 FEVER HIT 103.7. TESTED POSITIVE FOR STREP AT URGENT CARE CENTER. HOSPITALIZED ON 3/4/09 FEVER, RASH, BLISTERS, NOS STOP CRYING. DIAGNOSED WITH POST VACCINE CHICKENPOX. READMITTED ON 3/20/09 BANGING HIS HEAD, PULLING HAIR OUT, WEAKNESS ON RIGHT SIDE OF BODY, LOSS OF MOTOR SKILLS ON RIGHT SIDE, EXCESSIVE DROOLING,, FEVER, ENLARGED LIVER, CONSTIPATION, KIDNEY PROBLEMS, HIGH BLOOD PRESSURE(170/107). CURRENTLY IN PEDIATRIC INTENSIVE CARE UNIT  4/6/09 MR received for DOS 3/4-7/09 with DX: post vaccine varicella breakthrough.  Pt presented  with 10 day  hx of fever, coryza, diffuse rash and b/l upper and lower extremity swelling/edema.  PE (+) for erythematous tonsils, shotty lymphadenopathy, b/l tibial/foot/hand edema, diffuse maculopapular rash on trunk and extremities with several papular lesions. Recent strep pharyngitis dx on abx.  Pt had increased BPs during admission. Cont tx with abx. Sx not c/w Kawasaki.  4/16/09 Received ER admission beginning 3/20/09-5/9/09.  DIAGNOSIS: Impetigo.  Pruritis.  Rash.  Irritability.  Dysphagia.  Cardiac arrest. HTN.  SIADH. Fever. pt still hospitalized as of 4/8/09 and record not available. Pt returned to ER 3/20/09 for abnormal behavior-head banging, irritability and hair pulling.  Seen by PCP to be evaluated for ear infection and enlarged lymph nodes noted on exam. Fever x 1-2 days, sleeping poorly, inconsolable. PE (+) for tender irritated scab behind R ear from recent chicken pox, face flushed, petechiae lateral to R eye. Impression:  Skin infection 2' to scratching at healing chicken pox. Admitted to ID for R sided ear and facial pruritis, unimproved with Benadryl+Atarax. Given Valium-still restless and agitated. Still admitted as of 4/28/09.  6/4/09 Hospital records received DOS 3/20/09 to 5/9/09.  DIAGNOSIS: Impetigo.  Pruritis.  Rash.  Irritability.  Dysphagia.  Cardiac arrest. HTN.  SIADH. Fever. Post vaccination: Irritable, scratching face, pulling out hair. Decreased activity. Upon examination presents with rash and itching. Nervous and anxious.  System based hospital course:  CV - HDS with tachycardia. Patient coded with successful resusitation. Renal - Hypertension Pulmonary - Required intubation. Pulmonary function gradually improved and became stable. ID - Multiple antibiotics followed by resolution of infections. GI - Elevated LFT's. Hepatomegaly.  FEN - Intitially NPO. IVF changed to NS when concern for intracranial pathology. No electrolyte abnormalities. Foley catheter placed and later d/c'd. NJ feedings followed by G-tube placement. Hyponatremia, SIADH, placed on D50.9NS with improvement. NEURO/CNS - Significant mental status changes with discoordinate movement and truncal ataxia. Decreased use of right hand. Gradual improvement of mentation and motor skills. GU - Urinary retention of unknown etiology. HEME - Hematocrit and Hemoglobin dropped - considered iatrogenic.
Around 10 pm the evening of the immunization the patient felt very tired.  The next morning he woke up feeling achy all over, feverish and had a very sore arm.  He also had a drop of dried blood at the injection site.  He does not know if he truly has a fever as he has not checked his temperature but reports feeling feverish.
Approximate 20 minutes post vax, pt developed 2 flat red spots on right cheek which were hot and painful to touch.
Injection on 10/5/2023 was given high on the shoulder, likely into the bursa. Pain began later that evening, around 8PM and  has remained. When not moving, the should feels like it is burning deep inside the joint. It is painful to lift anything heavy with the left arm. It is painful to move the arm over my head, especially with the elbow bent, like when removing a shirt. I cannot sleep on the left side without waking up in extreme pain.  I saw my PCP on 10/25/2023 and she agreed this was caused by incorrect administration of the vaccine. She perscribed progesterone and referred me to Physical Therapy for further treatment if needed.
stroke; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old male patient received BNT162b2 (BNT162B2), on 21Feb2021 as dose 1, single (Lot number: VL-002624736) at the age of 67 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: CEREBROVASCULAR ACCIDENT (hospitalization, disability, life threatening) with onset 29Apr2021, outcome "recovered with sequelae", described as "stroke". The patient was hospitalized for cerebrovascular accident (hospitalization duration: 4 day(s)). The event "stroke" required physician office visit and emergency room visit. Therapeutic measures were taken as a result of cerebrovascular accident.  Clinical course: patient had no known allergies.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300026496 same product, patient, and event, different dose;
headache; 100.2 temp / temp now 97.2; This case was reported by a consumer via interactive digital media and described the occurrence of headache in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th December 2020 14:30, the patient received the 2nd dose of Shingrix. On 23rd December 2020, 5 days after receiving Shingrix, the patient experienced headache and fever. On an unknown date, the outcome of the headache and fever were not recovered/not resolved.   It was unknown if the reporter considered the headache and fever to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but it was captured as adult as per vaccine indication. The patient had headache and temperature in the morning of date of reporting. The patient had 100.2 temperature after drinking coffee and 97.2 temperature at 12:30. The reporter asked was it reaction to Shingrix.
PATIENT RECEIVED THE MODERNA VACCINE FOR DOSES 1 AND 2 AND THEN RECEIVED A BOOSTER OF PFIZER